Liu, L.; Yang, S.; Zheng, Z.; Li, Q.; Liu, C.; Hu, D.; Liu, Z.; Zhang, X.; Zhang, R.; Gao, D.
Biomimetic Theranostic Agents with Superior NIR-II Photoacoustic and Magnetic Resonance Imaging Performance for Targeted Photothermal Therapy of Prostate Cancer. Pharmaceutics 2023, 15, 1617.
https://doi.org/10.3390/pharmaceutics15061617
AMA Style
Liu L, Yang S, Zheng Z, Li Q, Liu C, Hu D, Liu Z, Zhang X, Zhang R, Gao D.
Biomimetic Theranostic Agents with Superior NIR-II Photoacoustic and Magnetic Resonance Imaging Performance for Targeted Photothermal Therapy of Prostate Cancer. Pharmaceutics. 2023; 15(6):1617.
https://doi.org/10.3390/pharmaceutics15061617
Chicago/Turabian Style
Liu, Ling, Shangpo Yang, Ziliang Zheng, Qingshuang Li, Chenchen Liu, Dehong Hu, Zhou Liu, Xiaoping Zhang, Ruiping Zhang, and Duyang Gao.
2023. "Biomimetic Theranostic Agents with Superior NIR-II Photoacoustic and Magnetic Resonance Imaging Performance for Targeted Photothermal Therapy of Prostate Cancer" Pharmaceutics 15, no. 6: 1617.
https://doi.org/10.3390/pharmaceutics15061617
APA Style
Liu, L., Yang, S., Zheng, Z., Li, Q., Liu, C., Hu, D., Liu, Z., Zhang, X., Zhang, R., & Gao, D.
(2023). Biomimetic Theranostic Agents with Superior NIR-II Photoacoustic and Magnetic Resonance Imaging Performance for Targeted Photothermal Therapy of Prostate Cancer. Pharmaceutics, 15(6), 1617.
https://doi.org/10.3390/pharmaceutics15061617
